School of Agriculture, Food and Ecosystem Sciences - Theses
Permanent URI for this collection
Search Results
1 - 1 of 1
-
ItemNon-phage inhibition of cheese starter lactococci( 2002)Modern, large scale Cheddar cheese manufacture is dependent on reliable acid production by Lactococcus lactis subspecies cremoris and subspecies lactis starter cultures. Any inhibition of acid production may affect cheese quality, disrupt production schedules and reduce profitability. The presence of antibiotic residues in manufacturing milk resulting from the treatment of mastitis in lactating cattle is a potential source of starter culture inhibition. Therefore, a range of antibiotic concentrations was assessed for measurable inhibitory effects on acid production and compared to the minimum detectable concentrations by approved screening test procedures. Antibiotics were selected from formulations approved for use on lactating cattle for the treatment of mastitis. Novobiocin, lincomycin, oleandomycin and oxytetracyline HCl, all non-β-lactam antibiotics, inhibited acid production of one or more L. lactis strains at antibiotic concentrations below the detectable limit of standard screening procedures. Depending on the antibiotic, either or both the Bacillus stearothermophilus (var. calidolactis) disk assay and/or the Delvo SP assay were ineffective at detecting the antibiotics at concentrations required to inhibit the starter strains. Consequently, antibiotic residues below the detectable limits of these testing procedures could cause significant starter culture inhibition, disrupting cheese making schedules. Another potential source of starter culture inhibition is related to raw milk quality and the practice of refrigerated storage prior to processing. Previous studies differed as to whether the growth of psychrotrophic organisms would have a detrimental impact on subsequent acid production by starter bacteria employed in cheese manufacture. In this study, no inhibition of acid production by a commercial L. lactis subsp. cremoris strain was evident when grown in milk that had undergone short term temperature abuse. Antimicrobial systems native to bovine milk may also have an adverse impact on starter culture performance. The present study assessed the inhibitory effect of an activated lactoperoxidase system (LPS) on a range of L. lactis cultures. All of the strains were significantly inhibited when grown on reconstituted skim milk in the presence of an active LPS. Inhibition of acid production by strains grown on glucose was also observed, leading to further investigations to describe the inhibitory process. A non-phosphoenolpyruvate phosphotransferase (PEP/PTS) dependent glucose transport system, first observed in 1980 in one L. lactis subsp. lactis strain, was hypothesised as a link in strain variations in LPS sensitivity. However, the LPS sensitive L. lactis subsp. cremoris strains tested did not take up glucose in a PEP depleted state, most likely due to their inability to utilise arginine as an ATP generating energy source. The questions remain unanswered whether cremoris strains possess this glucose transport mechanism and whether it could contribute to strain variations in LPS sensitivity. In a subsequent investigation, galactose phosphotransferase system (PTS) deficient L. lactis strain ATCC 7962 demonstrated log phase growth inhibition when grown on galactose in the presence of the model LPS. Previously reported LPS mediated effects on the glycolytic enzyme hexokinase do not appear to explain this result. The present study confirmed strain variability in sensitivity to the model LPS among both Lactococcus lactis subspecies lactis and subspecies cremoris strains. Further, the observation that dithiothreitol significantly alleviated the inhibition of a highly sensitive cremoris strain, implicated the involvement of sulphydryl groups as the target of the transient inhibitory factors. Data collected excluded the possibility that portions of the metabolic pathways involved in fructose and galactose metabolism are sensitive to the LPS in cells possessing PEP/PTS capability. This study also identified potential directions of further work to elucidate the mechanism(s) of LPS inhibition.